Herbal Monograph
Green tea
Camellia sinensis (L.) Kuntze
Theaceae
Antioxidant-rich leaf for liver protection, cardiovascular health, and calm m...
Overview
Plant Description
Evergreen shrub or small tree, 1-3 m tall when cultivated (up to 15 m if left unpruned in tropical conditions). Leaves alternate, simple, elliptic to oblong-lanceolate, 5-12 cm long, 2-4 cm wide, with serrate margins, glossy dark green above, lighter beneath, with prominent venation. Young leaves and buds are covered with fine silvery-white hairs (trichomes), which give white tea its name. Flowers solitary or in small clusters of 2-3, axillary, fragrant, 2.5-4 cm diameter, with 5-9 white petals and numerous yellow stamens. Fruit a flattened globose capsule, 1.5-2 cm diameter, containing 1-3 large brown seeds. The plant develops a deep taproot system. Commercially, plants are heavily pruned to maintain a low, flat-topped bush (approximately 1-1.5 m) to facilitate hand-harvesting of young shoots.
Habitat
Tropical and subtropical regions. Optimal growing conditions: temperatures 18-30°C (tolerates brief frost in var. sinensis but not sustained freezing), annual rainfall 1500-2500 mm evenly distributed, well-drained acidic soil (pH 4.5-5.5), high humidity. Grows from sea level to approximately 2200 m altitude; high-altitude teas (above 1200 m) are generally considered superior in flavor and catechin content due to slower growth. Shade-growing (as practiced for Japanese gyokuro and matcha) increases L-theanine and chlorophyll content while reducing catechin levels.
Distribution
Native to the border region of southwestern China (Yunnan province), northern Myanmar, and northeastern India (Assam). Now cultivated across tropical and subtropical Asia, East Africa, and parts of South America. Major producers: China (largest global producer, all tea types), India (primarily Assam and Darjeeling regions), Kenya (largest African producer), Sri Lanka, Japan (predominantly green tea, high-quality sencha and matcha), Vietnam, Indonesia, Turkey, and Argentina. Japan produces exclusively green tea and is noted for shade-grown cultivars with high L-theanine content.
Parts Used
Leaf (Folium Camelliae sinensis non fermentatum — unfermented/non-oxidized leaf)
Preferred: Loose-leaf infusion, powdered leaf (matcha), standardized extract capsules
Green tea is produced from unoxidized leaves, preserving the native catechin profile (particularly EGCG). This is the primary medicinal form studied in clinical trials and referenced in pharmacopeial monographs. The EMA monograph specifically covers 'non fermentatum folium' (unfermented leaf). Heat-treatment (steaming or pan-firing) immediately after harvest inactivates polyphenol oxidase, preventing catechin oxidation to theaflavins and thearubigins (which predominate in black tea). Japanese-style steaming produces a more vegetal, umami-rich tea; Chinese-style pan-firing produces a nuttier, more aromatic profile.
Leaf bud and young shoot tips
Preferred: Whole-leaf infusion, powdered (matcha)
The youngest tissues contain the highest concentration of catechins (especially EGCG), caffeine, and L-theanine. White tea (Bai Mu Dan, Silver Needle) is produced from buds with minimal processing. Premium Japanese green teas (gyokuro, matcha) are made from shade-grown young leaves with enhanced L-theanine content. The bud-to-leaf ratio affects both flavor and therapeutic constituent concentration.
Key Constituents
Catechins (flavan-3-ol polyphenols)
Catechins constitute 30-42% of dry weight of green tea leaves and are the primary bioactive class. EGCG alone accounts for the majority of green tea's pharmacological activity studied in clinical trials. Total catechin content per cup of brewed green tea typically ranges from 100-300 mg depending on tea grade, water temperature, and steeping time. Catechins are heat-sensitive: brewing at 70-80°C preserves catechins better than boiling water. During oxidation (black tea production), catechins are enzymatically converted to theaflavins and thearubigins, which have different (and generally reduced) pharmacological profiles.
L-Theanine (gamma-glutamylethylamide)
L-theanine is pharmacologically responsible for green tea's nootropic and anxiolytic effects. The L-theanine:caffeine ratio in green tea (approximately 1:1 to 2:1) is considered optimal for cognitive enhancement without anxiety. Shade-growing increases L-theanine concentration by preventing its photosynthetic conversion to catechins, which is why matcha and gyokuro have distinctly calming properties compared to sun-grown sencha. Clinical doses in cognitive studies range from 50-250 mg, achievable through 1-4 cups of quality green tea daily.
Methylxanthines (purine alkaloids)
Caffeine is the primary methylxanthine in green tea but present at lower concentrations than in coffee or black tea. The moderate caffeine content, combined with L-theanine modulation, produces a distinct psychoactive profile: sustained attention and alertness without the jitteriness or crash associated with higher-caffeine beverages. Caffeine also contributes to green tea's metabolic effects (thermogenesis) and may enhance catechin bioavailability.
Volatile compounds (essential oil fraction)
The volatile fraction is pharmacologically minor compared to catechins and L-theanine. However, the aromatic compounds contribute to the overall sensory experience and the traditional practice of tea ceremony, which itself has documented stress-reduction benefits independent of chemical constituents.
Vitamins, minerals, and other constituents
These constituents contribute to green tea's overall nutritional profile but are not the primary drivers of its therapeutic actions. Vitamin C content distinguishes green tea from black tea and may synergize with catechin antioxidant activity. Fluoride content is relevant for dental health claims but also for safety assessment in populations consuming large quantities.
Other polyphenols (non-catechin flavonoids)
Non-catechin polyphenols contribute to the overall antioxidant and anti-inflammatory activity of green tea but are secondary to catechins in terms of therapeutic significance. Quercetin in particular may enhance the bioavailability of EGCG through inhibition of multidrug resistance-associated protein (MRP) efflux transporters.
Herbal Actions
Prevents or slows oxidative damage to cells
Green tea catechins, particularly EGCG, are among the most potent dietary antioxidants characterized. EGCG demonstrates greater radical-scavenging capacity than vitamins C and E in cell-free assays. Mechanisms include direct free radical scavenging (hydroxyl radicals, superoxide, peroxyl radicals), chelation of pro-oxidant metal ions (Fe2+, Cu2+), induction of endogenous antioxidant enzymes via Nrf2/ARE pathway (glutathione S-transferase, superoxide dismutase, catalase), and inhibition of pro-oxidant enzymes (xanthine oxidase, NADPH oxidase). Epidemiological studies consistently associate green tea consumption with lower markers of oxidative stress. The antioxidant activity of green tea extract exceeds that of black tea due to preservation of catechins during processing.
[19, 20]Protects the liver from damage
Epidemiological evidence (Imai & Nakachi 1995) shows regular green tea consumption is associated with lower serum ALT and AST values. Saab et al. 2020 meta-analysis of 15 RCTs found nonsignificant overall reductions in liver enzymes (ALT: SMD -0.17, p=0.19) but subgroup analysis in NAFLD patients showed more favorable trends. Mechanisms include Nrf2-mediated induction of phase II detoxification enzymes, reduction of hepatic lipid accumulation, and suppression of hepatic NF-kB-mediated inflammation. CRITICAL PARADOX: While moderate green tea consumption appears hepatoprotective, high-dose concentrated EGCG supplements (>800 mg/day as bolus) carry documented hepatotoxicity risk. The hepatoprotective action applies to traditional tea consumption, not to high-dose supplementation.
[2, 11, 12]Reduces inflammation
EGCG inhibits NF-kB activation, suppresses COX-2 expression, and reduces pro-inflammatory cytokine production (TNF-alpha, IL-1beta, IL-6). Inhibits MAPK signaling cascades (p38, JNK, ERK). Demonstrated anti-inflammatory effects in clinical trials for osteoarthritis, metabolic syndrome, and periodontal disease. The anti-inflammatory mechanism overlaps with and supports the hepatoprotective, cardiovascular, and chemopreventive actions.
[19, 20]Enhances cognitive function, memory, and mental performance
The L-theanine and caffeine combination in green tea produces a unique nootropic effect characterized as 'calm alertness.' Haskell et al. 2008 RCT: 250 mg L-theanine + 150 mg caffeine improved simple reaction time, numeric working memory, and sentence verification accuracy beyond caffeine alone. Giesbrecht et al. 2010: even moderate doses (97 mg L-theanine + 40 mg caffeine, approximating one cup of green tea) improved task-switching accuracy and subjective alertness. L-theanine increases alpha brain wave activity within 30-40 minutes. The synergy is bidirectional: L-theanine attenuates caffeine-induced anxiety while caffeine prevents L-theanine-induced drowsiness.
[7, 8, 9]Strengthens and tones the heart muscle
Multiple meta-analyses demonstrate modest but consistent lipid-lowering effects. Zheng et al. 2011 meta-analysis of 14 RCTs: green tea reduced total cholesterol (-4.66 mg/dL) and LDL cholesterol (-4.55 mg/dL) with no effect on HDL or triglycerides. Kim et al. 2011 meta-analysis confirmed reductions in total cholesterol (-5.46 mg/dL) and LDL (-5.30 mg/dL). Kuriyama et al. 2006 Ohsaki cohort (40,530 adults): dose-dependent reduction in cardiovascular mortality with green tea consumption. Mechanisms include inhibition of cholesterol absorption, upregulation of hepatic LDL receptors, and improvement of endothelial function via increased nitric oxide bioavailability.
[4, 5, 6]Kills or inhibits the growth of microorganisms
EGCG demonstrates in vitro activity against a range of oral pathogens (Streptococcus mutans, Porphyromonas gingivalis), gastrointestinal pathogens (Helicobacter pylori, Clostridium difficile), and dermal pathogens (Propionibacterium acnes, Staphylococcus aureus including MRSA). Mechanisms include bacterial membrane disruption, inhibition of bacterial fatty acid synthesis (FabG, FabI), and inhibition of bacterial efflux pumps. Clinical relevance is best established for oral health: green tea consumption and green tea mouth rinses reduce plaque formation, gingivitis, and dental caries in clinical studies.
[19, 20]Increases urine production and output
Mild diuretic effect attributable primarily to caffeine content. Theophylline and theobromine contribute marginally. At moderate consumption (2-3 cups daily), the diuretic effect is minimal and does not cause net dehydration. Regular consumers develop tolerance to the diuretic effect of caffeine.
[1]Therapeutic Indications
Hepatobiliary System
Elevated liver enzymes and hepatoprotection
Imai & Nakachi 1995 cross-sectional study: regular green tea consumption associated with lower ALT, AST, and GGT values in 1,371 men. Saab et al. 2020 meta-analysis of 15 RCTs: overall nonsignificant reduction in ALT (SMD -0.17, p=0.19) but subgroup analysis in NAFLD patients showed more favorable trends. Green tea catechins reduce hepatic oxidative stress via Nrf2 pathway activation and decrease hepatic lipid accumulation. Aligns with clinical case study evidence showing normalization of elevated liver enzymes with a simple protocol of daily green tea, dandelion tea, and a liver support supplement over 2-3 months. IMPORTANT: Hepatoprotective effect applies to moderate tea consumption (2-5 cups/day); high-dose concentrated extracts >800 mg EGCG/day carry hepatotoxicity risk.
[2, 11, 12]Non-alcoholic fatty liver disease (NAFLD) support
Subgroup analysis from multiple RCTs suggests green tea catechins reduce hepatic fat accumulation and improve liver enzyme markers in NAFLD patients. Mechanisms include AMPK activation (enhancing hepatic fatty acid oxidation), suppression of de novo lipogenesis, and reduction of hepatic oxidative stress. Typical study doses: 500-1000 mg green tea catechins daily for 8-12 weeks. Consistent with green tea's role as a polyphenol-rich, low-cost intervention for metabolic liver disease.
[11]Cardiovascular System
Hyperlipidemia (elevated total and LDL cholesterol)
Zheng et al. 2011 meta-analysis of 14 RCTs: green tea significantly reduced total cholesterol (weighted mean -4.66 mg/dL) and LDL cholesterol (-4.55 mg/dL). No significant effect on HDL or triglycerides. Kim et al. 2011 meta-analysis confirmed reductions: total cholesterol (-5.46 mg/dL) and LDL (-5.30 mg/dL). A 1% reduction in LDL cholesterol is clinically associated with approximately 1% decreased cardiovascular disease risk. Green tea catechin doses in studies ranged from 145-3000 mg/day for 3-24 weeks. Effect is modest but clinically meaningful as part of a comprehensive cardiovascular risk reduction strategy.
[4, 5]Cardiovascular mortality risk reduction
Kuriyama et al. 2006 Ohsaki cohort study (40,530 adults, 7-11 year follow-up): green tea consumption showed a dose-dependent inverse association with cardiovascular disease mortality. Those consuming 5+ cups/day had significantly lower cardiovascular mortality compared to those consuming <1 cup/day. The association was stronger in women. Mechanisms include LDL reduction, improved endothelial function (increased NO bioavailability), antiplatelet activity, and antioxidant protection of LDL from oxidation.
[6]Nervous System
Cognitive enhancement and sustained attention
Multiple RCTs demonstrate the L-theanine + caffeine combination in green tea improves cognitive performance. Haskell et al. 2008: 250 mg L-theanine + 150 mg caffeine improved simple reaction time, numeric working memory, sentence verification accuracy, and reduced subjective fatigue beyond either compound alone. Giesbrecht et al. 2010: moderate doses (97 mg L-theanine + 40 mg caffeine, approximating one cup of green tea) improved task-switching accuracy (p<0.01) and alertness. Owen et al. 2008: 100 mg L-theanine + 50 mg caffeine improved switch task accuracy. The combination produces synergistic cognitive benefits exceeding either compound alone. L-theanine increases alpha brain wave activity, producing 'calm alertness' distinct from coffee-derived stimulation.
[7, 8, 9]Mental fatigue and reduced alertness
EMA traditional use indication: relief of fatigue and sensation of weakness. L-theanine modulates neurotransmission (increases GABA, serotonin, dopamine), producing calm wakefulness without overstimulation. Caffeine provides adenosine receptor antagonism for alertness. The combined effect addresses both subjective fatigue (reduced 'tiredness' ratings) and objective cognitive performance (improved accuracy and reaction time) simultaneously. Regular green tea consumption (3-5 cups daily) provides sustained cognitive support throughout the day.
[1, 7]Digestive System
Microbiome support and prebiotic activity
Jeong et al. 2020: green tea and EGCG increased relative abundance of Akkermansia muciniphila in high-fat diet-fed mice. EGCG identified as the sufficient factor for Akkermansia growth. A. muciniphila abundance is inversely correlated with obesity, type 2 diabetes, inflammatory bowel disease, and liver damage. Green tea polyphenols also promote growth of Lactobacillus, Bifidobacterium, and Blautia species while inhibiting pathogenic bacteria. Polyphenol-gut microbiota interaction is bidirectional: gut bacteria metabolize catechins into smaller bioactive phenolic acids. Evidence is primarily from animal and in vitro studies; human RCTs specifically demonstrating green tea-mediated Akkermansia enrichment are lacking.
[16]Endocrine System
Weight management and metabolic support
Hursel et al. 2009 meta-analysis of 11 RCTs: green tea catechins (with or without caffeine) had a small but significant positive effect on weight loss and weight maintenance. Effect size was modest. Moderators: greater effects in habitual low-caffeine consumers and Asian populations, suggesting caffeine tolerance and genetic factors (COMT polymorphisms) influence response. Mechanisms: catechins inhibit COMT (prolonging norepinephrine-mediated thermogenesis), caffeine inhibits phosphodiesterase (prolonging cAMP signaling), and EGCG activates AMPK in adipose tissue. Green tea is not a weight-loss drug but may provide modest metabolic support as part of a comprehensive approach.
[10]Blood glucose regulation
Some clinical evidence suggests green tea catechins may improve insulin sensitivity and reduce fasting blood glucose. Mechanisms include AMPK activation, inhibition of intestinal glucose transporters (SGLT1, GLUT2), and reduction of hepatic gluconeogenesis. Evidence is inconsistent across studies, with effect sizes generally small. Not a substitute for established diabetes management.
[4]Immune System
Cancer chemoprevention
Epidemiological evidence from large prospective cohorts suggests an association between green tea consumption and reduced cancer risk, particularly for some cancer types. Imai, Suga & Nakachi 1997: 8,552 individuals, 9-year follow-up — relative risk for cancer incidence was 0.59 (95% CI 0.35-0.98) for those consuming >10 cups/day vs. <3 cups/day. Kuriyama 2006 Ohsaki cohort: weaker and sex-dependent cancer mortality association. Mechanisms: EGCG inhibits angiogenesis (VEGF suppression), induces apoptosis, inhibits telomerase, and modulates epigenetic processes (DNMT inhibition). However, evidence remains epidemiological/observational; no human RCTs demonstrate cancer prevention. Animal and in vitro evidence is robust but translation to clinical prevention is unconfirmed.
[6, 13, 20]Energetics
Temperature
cool
Moisture
slightly dry
Taste
Tissue States
heat/excitation, damp/stagnation
Green tea is classified as cool and slightly dry across traditional systems. In TCM, green tea (lu cha) is considered cool, bitter, and sweet, entering the heart, lung, and stomach channels. It clears heat, resolves toxin, promotes urination, and calms the spirit (an shen). Green tea is appropriate for heat-type patterns and is traditionally avoided in cold-deficiency patterns and in excess on an empty stomach (as it can 'injure the spleen yang'). The cooling, bitter quality distinguishes green tea from the more neutral or warming properties ascribed to aged and fermented teas (e.g., shu pu-erh, which is warm). In Ayurveda, green tea is considered astringent (kashaya) and bitter (tikta) with a cooling energy (shita virya). It reduces pitta and kapha but may aggravate vata in excess due to its drying and astringent qualities. In Western energetic terms, green tea is cooling and drying, indicated for heat-excess and damp-stagnation tissue states. Its astringent tannins tone lax tissue while its bitter components stimulate hepatic and digestive function.
Traditional Uses
Traditional Chinese Medicine (TCM)
- Lu cha (green tea): Clear heat and resolve toxin (qing re jie du)
- Promote urination and relieve edema
- Aid digestion and resolve food stagnation, especially after greasy or heavy meals
- Calm the spirit (an shen) and promote mental clarity
- Brighten the eyes and relieve headache from heat patterns
- Counteract the effects of alcohol consumption
- Cool the blood in heat-type bleeding conditions
"Tea was first described in Shen Nong Ben Cao Jing (Divine Husbandman's Classic of the Materia Medica, c. 200 CE) as a medicine, and later extensively documented in Lu Yu's Cha Jing (Classic of Tea, 760 CE) as both a medicinal and cultural beverage. In TCM, green tea is classified as bitter (ku), sweet (gan), and cool (liang), entering the heart, lung, and stomach channels. It is considered most appropriate for heat-excess constitutions and is traditionally cautioned against excessive consumption in those with spleen-yang deficiency or cold constitutions, as it may 'injure the stomach' (shang wei)."
[19]
Japanese tea tradition
- Matcha (powdered green tea): Consumed during Zen Buddhist meditation for sustained concentration and calm alertness
- Sencha: Daily health-promoting beverage for longevity and disease prevention
- Bancha and hojicha: Gentle digestive tea suitable for children and elderly
- Green tea gargling: Prevention of influenza and upper respiratory infections (common practice in Japanese schools)
- External application of used tea leaves (chagara) as a poultice for minor skin irritation
"Tea was introduced to Japan from China by Buddhist monks in the 9th century. The Zen monk Eisai (1141-1215) wrote Kissa Yojoki (How to Stay Healthy by Drinking Tea, 1211), the first Japanese treatise on tea and health, declaring tea 'a medicine for the ages.' The Japanese tea ceremony (chanoyu) developed from Zen Buddhist practice, emphasizing mindfulness and presence. The specific cultivation of shade-grown tea for matcha production (beginning in the 14th-15th centuries) was driven by monks seeking the combined alertness and calm that matcha uniquely provides through its high L-theanine content."
[19]
Ayurveda
- Digestive stimulant after heavy meals
- Mild diuretic for fluid retention
- Mental alertness and concentration
- Reduction of kapha (heaviness, congestion, lethargy)
"Tea was not traditionally part of classical Ayurvedic practice (which predates tea's introduction to India). However, tea consumption became widespread in India during British colonial rule (19th-20th centuries) and has since been incorporated into South Asian traditional health practices. In Ayurvedic terms, green tea is characterized as astringent (kashaya) and bitter (tikta) with cooling energy (shita virya). It is best suited for pitta and kapha constitutions and may aggravate vata if consumed in excess due to its drying and astringent properties."
[19]
European and Western Herbalism
- Stimulant and tonic for fatigue and mental dullness
- Diuretic for mild fluid retention
- Antioxidant-rich beverage for cardiovascular health
- Digestive aid after meals
- Weight management support
"Tea was introduced to Europe in the 17th century, initially as a medicinal curiosity and luxury commodity. European herbalists adopted tea primarily for its stimulant properties. The Eclectic physicians of the 19th century recognized tea as a nervous system stimulant and mild diuretic. In contemporary Western herbalism, green tea is valued primarily for its polyphenol content and used as part of cardiovascular, hepatoprotective, and metabolic support protocols."
[17]
Modern Research
Meta-analysis of green tea effects on liver enzymes
Systematic review and meta-analysis of 15 randomized clinical trials evaluating the effects of green tea or green tea catechins on liver enzymes in healthy individuals and people with NAFLD.
Findings: Overall effects were nonsignificant: ALT (SMD = -0.17, 95% CI -0.42 to 0.08, p = 0.19), AST (SMD = -0.07, 95% CI -0.43 to 0.29, p = 0.69), ALP (SMD = -0.17, 95% CI -0.45 to 0.1, p = 0.22). Subgroup analysis showed more favorable trends in NAFLD populations. Epidemiological data consistently shows green tea drinkers have lower baseline liver enzyme levels.
Limitations: Heterogeneous populations (healthy vs. NAFLD). Variable doses and preparations across trials. Some studies used green tea beverages, others used concentrated extracts, limiting comparability. Short study durations in many trials.
[11]
Meta-analysis of green tea and serum lipid levels
Meta-analysis of 14 randomized controlled trials evaluating the effects of green tea consumption on fasting serum total and LDL cholesterol in adults.
Findings: Green tea beverages or extracts significantly reduced total cholesterol (weighted mean difference: -4.66 mg/dL) and LDL cholesterol (-4.55 mg/dL). No significant effects on HDL cholesterol or triglycerides. This corresponds to approximately 2-5% reductions in total and LDL cholesterol, which translates to a clinically meaningful reduction in cardiovascular disease risk at a population level.
Limitations: Modest effect sizes. Heterogeneous doses and preparations. Most studies were short-term (3-24 weeks). Long-term effects on hard cardiovascular endpoints not assessed in RCTs.
[4]
L-theanine and caffeine synergy for cognitive performance
Randomized, placebo-controlled, double-blind crossover study evaluating the acute effects of L-theanine (250 mg) and caffeine (150 mg), alone and in combination, on cognition and mood in healthy adults.
Findings: The L-theanine + caffeine combination improved simple reaction time, numeric working memory reaction time, sentence verification accuracy, and RVIP accuracy compared to placebo. It also reduced self-reported 'tiredness' and 'headache' ratings while increasing 'alertness.' Caffeine alone improved only digit vigilance RT and RVIP accuracy. L-theanine alone showed no significant cognitive benefits. The combination produced synergistic effects exceeding either compound alone.
Limitations: Single-dose acute study. Small sample size. Doses higher than those obtained from typical tea consumption (would require approximately 4-5 cups of strong green tea). Short assessment window (90 minutes post-dose).
[7]
Moderate-dose L-theanine and caffeine for task-switching and alertness
Randomized placebo-controlled study evaluating the combination of moderate L-theanine (97 mg) and caffeine (40 mg) — doses approximating a single cup of green tea — on cognitive performance and mood.
Findings: The combination significantly improved accuracy during task switching (p < 0.01), increased self-reported alertness (p < 0.01), and reduced self-reported tiredness (p < 0.05). These effects were observed at doses achievable from a single cup of quality green tea, supporting the ecological validity of green tea's cognitive benefits.
Limitations: Acute single-dose study. Effects may not generalize to chronic consumption patterns. Individual variation in caffeine sensitivity not fully controlled.
[8]
Green tea consumption and all-cause and cardiovascular mortality: the Ohsaki cohort
Large prospective cohort study of 40,530 Japanese adults (aged 40-79) followed for 7-11 years, examining the association between green tea consumption and mortality from cardiovascular disease, cancer, and all causes.
Findings: Green tea consumption was inversely associated with cardiovascular disease mortality in a dose-dependent manner. Compared with <1 cup/day, consumption of 5+ cups/day was associated with significantly lower cardiovascular mortality. The association was stronger in women. All-cause mortality was also inversely associated with green tea consumption. The association with cancer mortality was weaker and less consistent.
Limitations: Observational design — cannot establish causation. Potential confounding by other dietary and lifestyle factors (healthy user effect). Self-reported tea consumption. Single assessment of tea consumption at baseline.
[6]
Green tea catechins for weight loss and weight maintenance
Meta-analysis of 11 randomized controlled trials evaluating the effects of green tea catechins (with or without caffeine) on body weight loss and weight maintenance.
Findings: Green tea catechins or EGCG-caffeine mixtures had a small but statistically significant positive effect on weight loss and weight maintenance. Habitual caffeine intake and ethnicity were identified as significant moderators: greater effects in habitual low-caffeine consumers and in Asian populations (potentially related to COMT gene polymorphisms affecting catechin metabolism).
Limitations: Small overall effect size. Significant heterogeneity across studies. Moderating effects of ethnicity and caffeine habituation complicate generalizability. Most studies were short-term (12 weeks or less).
[10]
Green tea polyphenols and Akkermansia muciniphila growth
In vitro and animal study investigating the effect of green tea and EGCG on the growth of Akkermansia muciniphila, a mucosal symbiont associated with metabolic health.
Findings: Green tea and EGCG increased the relative abundance of Akkermansia muciniphila in high-fat diet-fed mice. EGCG was identified as the sufficient factor for promoting Akkermansia growth. A. muciniphila abundance is inversely correlated with metabolic disturbances including obesity, type 2 diabetes, and liver damage.
Limitations: Animal and in vitro study. Translation to human gut microbiome effects not established. Dose-response relationship in humans unknown. No human RCTs available for this specific indication.
[16]
EFSA safety assessment of green tea catechins
Comprehensive safety evaluation by the European Food Safety Authority assessing the risk of liver injury from green tea catechin intake, particularly EGCG, in food supplements.
Findings: EGCG doses at or above 800 mg/day taken as food supplement (bolus dose) were associated with increased risk of liver damage. No evidence of hepatotoxicity below 800 mg EGCG/day in clinical trials up to 12 months. An observed safe level of 338 mg EGCG/day was established for concentrated solid bolus doses; 704 mg EGCG/day for beverage-form consumption. Green tea beverages consumed traditionally do not pose hepatotoxicity risk. Risk factors include fasting state, pre-existing liver conditions, and certain genetic polymorphisms (COMT, UGT1A4).
Limitations: Case reports and clinical trial adverse events form the evidence base. Idiosyncratic hepatotoxicity means individual susceptibility varies. Genetic susceptibility markers not yet validated for clinical screening.
[2]
Preparations & Dosage
Infusion (Tea)
Strength: 2-3 g loose leaf per 240 mL (8 oz) water at 70-80°C
Place 2-3 g (approximately 1 teaspoon) of loose-leaf green tea in a teapot or infuser. Heat water to 70-80°C (160-175°F) — NOT boiling, as temperatures above 85°C degrade catechins and increase bitterness from excessive tannin extraction. Pour water over leaves, steep for 2-3 minutes (first infusion). High-quality green tea can be re-infused 2-3 times. For maximum catechin extraction: use hotter water (80°C) and longer steeping (3-5 minutes), but with increased bitterness. For maximum L-theanine and umami: use cooler water (60-70°C) and shorter steeping (1-2 minutes).
2-5 cups (480-1200 mL) daily. Each cup provides approximately 50-150 mg catechins, 20-50 mg L-theanine, and 25-50 mg caffeine depending on tea grade and preparation method.
Throughout the day, preferably between meals (not on an empty stomach, which may cause nausea in sensitive individuals)
Safe for long-term daily consumption. Epidemiological studies demonstrating benefits are based on habitual, long-term consumption patterns.
Children over 12: 1-2 cups daily. Not recommended for younger children due to caffeine content. Roasted green tea (hojicha) or bancha are lower in caffeine and traditionally considered suitable for older children in Japan.
The traditional and most well-studied preparation. Water temperature is critical: 70-80°C preserves catechin integrity and minimizes bitter tannin extraction. Japanese green teas (sencha, gyokuro) are generally brewed at lower temperatures (60-70°C) than Chinese green teas (70-85°C). Adding a small amount of lemon juice or vitamin C may enhance catechin stability and bioavailability in the beverage. Do not add milk: casein proteins bind catechins and may reduce their bioavailability.
Capsule / Powder
Strength: Standardized to 45-50% EGCG (approximately 225-250 mg EGCG per 500 mg capsule). Decaffeinated options available.
Green tea extract capsules containing standardized catechin/EGCG content. Take with food (not on an empty stomach) to reduce hepatotoxicity risk.
250-500 mg green tea extract (standardized to 45-50% EGCG), 1-2 times daily with meals. Do NOT exceed 800 mg EGCG per day from supplements (EFSA safety threshold).
1-2 times daily with food
Clinical trials have used supplemental doses safely for up to 12 months at doses below 800 mg EGCG/day. Periodic liver function monitoring (ALT, AST) is prudent for long-term high-dose supplementation.
Not recommended for children in supplement form.
Supplement form delivers higher catechin doses than tea infusion. CRITICAL SAFETY NOTE: EFSA established 800 mg EGCG/day as the threshold above which liver damage risk increases. Always take with food. Avoid fasted-state consumption of green tea extract supplements. Choose products from reputable manufacturers with third-party testing. Decaffeinated extracts are available for those sensitive to caffeine. USP requires a hepatotoxicity warning on decaffeinated green tea extract products (effective March 2019).
Standardized Extract
Strength: Variable. Common standardizations: 50% EGCG, 80% catechins, or 95% total polyphenols.
Commercially prepared extracts standardized to specific catechin or EGCG content. Available as tablets, capsules, or liquid extracts.
Products vary. Typical standardization: 45-98% polyphenols, 50-80% catechins, 25-50% EGCG. Follow manufacturer's dosing. General guideline: 300-400 mg total polyphenols daily (per EMA traditional use recommendation). Do not exceed 800 mg EGCG/day.
1-2 times daily with meals
As directed. Monitor hepatic function with prolonged use at higher doses.
Not established for standardized extracts.
Standardized extracts provide more consistent dosing than whole-leaf preparations but carry higher risk of hepatotoxicity at equivalent catechin doses due to bolus delivery. The distinction between beverage consumption and concentrated extract supplementation is pharmacokinetically and toxicologically significant: catechins from tea are absorbed gradually with food, while supplement bolus doses produce higher peak plasma concentrations that may overwhelm hepatic detoxification capacity.
[2]
Tincture
Strength: 1:5, 45-60% ethanol
Macerate dried green tea leaf in 45-60% ethanol at 1:5 ratio for 2-4 weeks. Shake daily. Press and filter.
2-4 mL, 2-3 times daily
2-3 times daily
As needed
Not recommended (alcohol content and caffeine).
Less common preparation for green tea. Ethanol extraction captures catechins, caffeine, and L-theanine effectively. May be used in herbal formulations where a liquid form is preferred. Less studied than infusion or capsule forms in clinical trials.
[17]
Safety & Interactions
Class 1
Can be safely consumed when used appropriately (AHPA Botanical Safety Handbook)
Contraindications
Rare but documented. Allergic reactions to green tea are uncommon but have been reported, including contact dermatitis and, rarely, anaphylaxis. Cross-reactivity with other Theaceae members is theoretically possible.
While moderate green tea beverage consumption appears hepatoprotective, concentrated green tea extract supplements deliver high bolus doses of EGCG that may overwhelm hepatic detoxification capacity in individuals with compromised liver function. Mazzanti et al. 2009 reviewed 19 cases of green tea-associated hepatotoxicity; EFSA 2018 established 800 mg EGCG/day as the risk threshold for supplements. This contraindication applies specifically to concentrated extract supplements, NOT to traditional tea beverage consumption.
Drug Interactions
| Drug / Class | Severity | Mechanism |
|---|---|---|
| Warfarin and other vitamin K-dependent anticoagulants (Anticoagulants) | moderate | Green tea contains vitamin K1 (phylloquinone), approximately 0.03 mg per cup, which can antagonize warfarin's anticoagulant effect. Additionally, green tea catechins may inhibit platelet aggregation via thromboxane inhibition (opposing the vitamin K effect). The net clinical effect depends on consumption pattern. Large, sudden changes in green tea consumption may alter INR. |
| Iron supplements and iron-rich foods (Minerals / nutritional supplements) | moderate | Green tea catechins (particularly EGCG and EGC) chelate non-heme iron in the gastrointestinal tract, reducing its absorption by up to 60-70%. This effect is specific to non-heme (plant-based) iron; heme iron absorption is less affected. |
| Nadolol and other beta-blockers (Beta-adrenergic blocking agents) | moderate | Green tea has been shown to reduce the bioavailability of nadolol by inhibiting organic anion transporting polypeptide (OATP1A2)-mediated intestinal absorption. A pharmacokinetic study demonstrated a 85% reduction in nadolol peak plasma concentration when co-administered with green tea. |
| Stimulant medications (methylphenidate, amphetamines) and other caffeine sources (CNS stimulants) | minor | Additive stimulant effects due to caffeine content in green tea. Combined use may increase heart rate, blood pressure, nervousness, and insomnia. |
Pregnancy & Lactation
Pregnancy
likely safe
Lactation
likely safe
Pregnancy: Moderate green tea consumption (2-3 cups/day, approximately 100-200 mg caffeine) is generally considered safe during pregnancy. Major health organizations recommend limiting total caffeine intake to 200-300 mg/day during pregnancy. Green tea at moderate intake falls within this range when it is the primary caffeine source. High-dose green tea extract supplements are NOT recommended during pregnancy due to: (1) potential hepatotoxicity risk, (2) catechins may interfere with folic acid metabolism (EGCG inhibits dihydrofolate reductase at high concentrations), and (3) high caffeine doses are associated with increased risk of miscarriage and low birth weight. Lactation: Caffeine from green tea passes into breast milk (approximately 1% of maternal dose). At moderate consumption (2-3 cups/day), the amount transferred is unlikely to affect the infant. Very high consumption may cause irritability and sleep disruption in breastfed infants. Catechin transfer to breast milk is poorly characterized. Traditional use of green tea during lactation is widespread in East Asian cultures without documented adverse infant effects.
Adverse Effects
References
Monograph Sources
- [1] Committee on Herbal Medicinal Products (HMPC), European Medicines Agency. Community herbal monograph on Camellia sinensis (L.) Kuntze, non fermentatum folium. European Medicines Agency (2013)
- [2] EFSA Panel on Food Additives and Nutrient Sources Added to Food (ANS). Scientific opinion on the safety of green tea catechins. EFSA Journal (2018) ; 16 : e05239 . DOI: 10.2903/j.efsa.2018.5239 . PMID: 32625874
- [3] National Center for Complementary and Integrative Health (NCCIH). Green Tea. NCCIH, National Institutes of Health (2023)
Clinical Studies
- [4] Zheng XX, Xu YL, Li SH, Liu XX, Hui R, Huang XH. Green tea intake lowers fasting serum total and LDL cholesterol in adults: a meta-analysis of 14 randomized controlled trials. Am J Clin Nutr (2011) ; 94 : 601-610 . DOI: 10.3945/ajcn.110.010926 . PMID: 21715508
- [5] Kim A, Chiu A, Barone MK, Avino D, Wang F, Coleman CI, Bhatt DL. Green tea catechins decrease total and low-density lipoprotein cholesterol: a systematic review and meta-analysis. J Am Diet Assoc (2011) ; 111 : 1720-1729 . DOI: 10.1016/j.jada.2011.08.009 . PMID: 22027055
- [6] Kuriyama S, Shimazu T, Ohmori K, Kikuchi N, Nakaya N, Nishino Y, Tsubono Y, Tsuji I. Green tea consumption and mortality due to cardiovascular disease, cancer, and all causes in Japan: the Ohsaki study. JAMA (2006) ; 296 : 1255-1265 . DOI: 10.1001/jama.296.10.1255 . PMID: 16968850
- [7] Haskell CF, Kennedy DO, Milne AL, Wesnes KA, Scholey AB. The effects of L-theanine, caffeine and their combination on cognition and mood. Biol Psychol (2008) ; 77 : 113-122 . DOI: 10.1016/j.biopsycho.2007.09.008 . PMID: 18006208
- [8] Giesbrecht T, Rycroft JA, Rowson MJ, De Bruin EA. The combination of L-theanine and caffeine improves cognitive performance and increases subjective alertness. Nutr Neurosci (2010) ; 13 : 283-290 . DOI: 10.1179/147683010X12611460764840 . PMID: 21040626
- [9] Owen GN, Parnell H, De Bruin EA, Rycroft JA. The combined effects of L-theanine and caffeine on cognitive performance and mood. Nutr Neurosci (2008) ; 11 : 193-198 . DOI: 10.1179/147683008X301513 . PMID: 18681988
- [10] Hursel R, Viechtbauer W, Westerterp-Plantenga MS. The effects of green tea on weight loss and weight maintenance: a meta-analysis. Int J Obes (2009) ; 33 : 956-961 . DOI: 10.1038/ijo.2009.135 . PMID: 19597519
- [11] Saab S, Mallam D, Cox GA, Tong MJ. Effects of green tea or green tea catechin on liver enzymes in healthy individuals and people with nonalcoholic fatty liver disease: a systematic review and meta-analysis of randomized clinical trials. Phytother Res (2020) ; 34 : 1587-1598 . DOI: 10.1002/ptr.6637 . PMID: 32067271
- [12] Imai K, Nakachi K. Cross sectional study of effects of drinking green tea on cardiovascular and liver diseases. BMJ (1995) ; 310 : 693-696 . PMID: 7711535
- [13] Imai K, Suga K, Nakachi K. Cancer-preventive effects of drinking green tea among a Japanese population. Prev Med (1997) ; 26 : 769-775 . PMID: 9388788
- [14] Mazzanti G, Menniti-Ippolito F, Moro PA, Cassetti F, Raschetti R, Santuccio C, Mastrangelo S. Hepatotoxicity from green tea: a review of the literature and two unpublished cases. Eur J Clin Pharmacol (2009) ; 65 : 331-341 . DOI: 10.1007/s00228-008-0610-7 . PMID: 19198822
- [15] Mazzanti G, Di Sotto A, Vitalone A. Hepatotoxicity of green tea: an update. Arch Toxicol (2015) ; 89 : 1175-1191 . DOI: 10.1007/s00204-015-1521-x . PMID: 25975988
- [16] Jeong HW, Kim JK, Kim AY, Cho D, Lee JH, Choi JK, Park M, Kim W. Green tea encourages growth of Akkermansia muciniphila. J Med Food (2020) ; 23 : 841-851 . DOI: 10.1089/jmf.2019.4662 . PMID: 32598202
Traditional Texts
- [17] Hoffmann D. Medical Herbalism: The Science and Practice of Herbal Medicine. Healing Arts Press, Rochester, Vermont (2003)
- [18] Bone K, Mills S. Principles and Practice of Phytotherapy: Modern Herbal Medicine (2nd edition). Churchill Livingstone/Elsevier (2013)
Pharmacopeias & Reviews
- [19] Cabrera C, Artacho R, Gimenez R. Beneficial effects of green tea -- a review. J Am Coll Nutr (2006) ; 25 : 79-99 . DOI: 10.1080/07315724.2006.10719518 . PMID: 16582024
- [20] Khan N, Mukhtar H. Tea and health: studies in humans. Curr Pharm Des (2013) ; 19 : 6141-6147 . DOI: 10.2174/1381612811319340008 . PMID: 23448443
Last updated: 2026-03-01 | Status: published
Unlock the Full Materia Medica
This monograph is part of our complete evidence-based herbal reference. Enter your email to get free, unlimited access to all of our monographs.
No spam, ever. Unsubscribe anytime.
You're In!
You now have full access to all of our herbal monographs.